Full Text View
Tabular View
No Study Results Posted
Related Studies
Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
This study has been completed.
Study NCT00610610   Information provided by Duke University
First Received: January 28, 2008   Last Updated: February 7, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fibromyalgia Syndrome
Additional conditions recognized in this trial
Fibromyalgia
Myofascial Pain Syndromes
Syndrome
More general conditions related to this trial
Disease
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Pathologic Processes
Rheumatic Diseases
Interventions listed in this trial
Paroxetine CR
Placebo
Additional drug interventions recognized in this trial
Paroxetine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Duke University
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services